Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prolonged bleeding time due to mitotane therapy.

H R Haak1, K M Caekebeke-Peerlinck, A P van Seters

  • 1Department of Endocrinology, University Hospital Leiden, The Netherlands.

European Journal of Cancer (Oxford, England : 1990)
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of diagnostic measurements in patients with non-specific complaints: A secondary analysis after implementation of a care-pathway in the emergency department.

PloS one·2025
Same author

Evaluation of a care pathway for older adults presenting with nonspecific complaints at the emergency department: a before-and-after study.

European geriatric medicine·2025
Same author

Risk factors for hospitalisation in community-dwelling pre-frail and frail older people: results of a longitudinal study.

BMC geriatrics·2024
Same author

Implementation of a care-pathway at the emergency department for older people presenting with nonspecific complaints; a protocol for a multicenter parallel cohort study.

PloS one·2023
Same author

Breakfast partly restores the anti-inflammatory function of high-density lipoproteins from patients with type 2 diabetes mellitus.

Atherosclerosis plus·2023
Same author

Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same journal

Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Phase I/Ib study evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of NIZ985 monotherapy and in combination with an anti-PD-1 agent in patients with advanced solid tumors or lymphoma.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinical urgency of incidental findings in the first year of the 4-IN-THE-LUNG-RUN lung cancer screening program.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials.

European journal of cancer (Oxford, England : 1990)·2026
See all related articles

Mitotane therapy for adrenocortical cancer can prolong bleeding times and impair platelet function, potentially causing an aspirin-like defect in some patients. This finding highlights a significant clinical risk associated with mitotane treatment.

Area of Science:

  • Oncology
  • Hematology
  • Pharmacology

Background:

  • Adrenocortical cancer is a rare malignancy.
  • Mitotane is a key chemotherapeutic agent used in adrenocortical cancer treatment.
  • Potential side effects of mitotane require thorough investigation.

Purpose of the Study:

  • To prospectively investigate the effect of mitotane on platelet function and coagulation parameters.
  • To determine if mitotane therapy is associated with prolonged bleeding times.
  • To characterize the nature of platelet dysfunction induced by mitotane.

Main Methods:

  • Prospective study of 7 patients with adrenocortical cancer receiving mitotane.
  • Measurement of platelet counts, bleeding times, and global coagulation parameters.

Related Experiment Videos

  • Assessment of platelet aggregation responses before and after mitotane initiation.

    • Main Results:

    • All patients had normal bleeding times prior to mitotane treatment.
    • Bleeding times were significantly prolonged in 6 out of 7 patients during mitotane therapy (245-555 s).
    • Four patients showed platelet aggregation defects similar to aspirin-induced dysfunction.

    Conclusions:

    • Mitotane therapy can induce a clinically relevant defect in platelet function.
    • The observed platelet dysfunction may contribute to prolonged bleeding times.
    • Mitotane's impact on hemostasis warrants careful monitoring in patients with adrenocortical cancer.